Airway obstruction and chronic exertional dyspnoea in patients with persistent bronchial asthma  by FILIPPELLI, M. et al.
Airway obstruction and chronic exertional dyspnoea
in patients with persistent bronchial asthma
M. FILIPPELLI{, F. PACINI{, I. Romagnoli*,{, E. ROSI*,{, R. OTTANELLI*, R. DURANTI*,{
AND G. SCANO*,{
*Section of Pneumology, Department of Internal Medicine, University of Florence and { Fondazione Don C.
Gnocchi ONLUS, Pozzolatico, Florence, Italy
In patients with COPD, flow limitation (FL) predicts chronic exertional dyspnoea (CED) better than routine
spirometry. Whether, and to what extent, FL and CED are overlapping quantities in chronic asthma has not yet
been defined. Forty consecutive clinically stable asthmatic patients without smoking history or cardiopulmonary
disorders, were studied. In each subject respiratory function, including static and dynamic pulmonary volumes, was
evaluated; maximal (MEFV) and partial (PEFV) expiratory V’–V curves and isovolumic partial to maximal flow
ratio (M/P). FL was assessed in a seated patient by comparing tidal and PEFV curves; FL was detected when tidal
flows were superimposed or exceeded those obtained during PEFV curves, and was expressed as a percentage of the
expired control tidal volume (VT) aected by flow limitation (FL%VT). Dyspnoea was assessed by both MRC scale
and Baseline Dyspnoea Index (BDI) focal score. Half of the patients were found to have FL. They were older, more
dyspnoeic and more obstructed (P50?03 – P50?000005) than the non-FL group. FEV1, vital capacity (VC), age,
body mass index, FL and M/P ratio were all related to dyspnoea scores. FL was significantly related to FEV1 (r=
70?59). Multiple regression analysis showed that FEV1 (P=0?003, r
2= 15?3% and P= 0?004, r2= 20?3%) and age
(P= 0?0006, r2= 26?8% and P= 0?016, r2= 11%) independently predicted a part of the variance of MRC (P=
0?0001, r2 = 42?1%) and BDI (P = 0?0008, r2 = 31?3%), respectively. With dyspnoea scale being the gold
standard, diagnostic accuracy (sensitivity and specificity) by ROC (receiver operating characteristics) analysis was
similar for FEV1 and FL. The results indicate that FL may be present in this subset of asthmatics. CED may not be
easily explained by abnormalities of routine spirometry or FL, the largest part of the CED variance remained
unexplained. Thus, routine spirometry, FL and CED in patients with bronchial asthma are only partially
overlapping quantities which need to be assessed separately.
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In chronic asthma, as in other respiratory disorders,
breathlessness occurring during living daily activity is
referred to as chronic exertional dyspnoea (CED). CED is
scored by both the traditional Medical Research Council
scale (MRC), and a focal score of baseline dyspnoea index
(BDI). BDI includes the components of functional impair-
ment, magnitude of eort and magnitude of task (1,2).
Many attempts to relate clinical ratings of dyspnoea to
simple physiological respiratory variables show a wide
overlap in these relationships (1–4), confirming the multi-
factorial nature of dyspnoea (5). Mahler et al. (2) haveReceived 19 April 1999 and accepted in revised form 26 January
2000.
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0954-6111/00/070694+08 $35?00/0shown that the relationships between dyspnoea and FEV1
or FVC are weak in patients with chronic obstructive
pulmonary disease (COPD) and significantly higher in
patients with asthma. More recently, Eltayara et al. (6) have
shown that in patients with COPD, flow limitation (FL),
which is due to intrinsic disease of the airway and loss of
elastic recoil, is strongly related to the MRC score and
predicts CED much better than FEV1. In patients with
chronic bronchial asthma whereby the isovolume pressure
flow curve is qualitatively similar to that in patients with
COPD (7), static airway narrowing and possibly loss of
lung–airway inter-dependence (8) are potentially responsi-
ble for FL. However, patients with chronic asthma with
mild levels of dyspnoea have been reported to be non-flow
limited by Boczkowski et al. (9). This finding does not argue
against the possibility that in chronic asthma more severe
CED may be associated with some FL.
Thus, the present investigation was carried out to assess
the presence of FL in chronic bronchial asthma and to
determine the extent, if any, it contributes to CED.# 2000 HARCOURT PUBLISHERS LTD
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PATIENTS
Forty consecutive non-smoking patients (15 males and 25
females) aged 18–70 (median age 42 years) with stable,
chronic, bronchial asthma, according to the criteria of the
National Heart, Lung and Blood Institute (NHLBI) (10),
participated in the study.
Asthma was characterized by a history of episodes of
dyspnea with wheezing and >15% FEV1 increase from
baseline after inhalation of 100 mg of a b2-bronchodilator
agent and by bronchial hyperresponsiveness to histamine
[provocative concentration of histamine causing 20% fall in
FEV1 (PC20FEV1)<8 mgml
71)] (11). Asthma was classi-
fied as mild (n=20), moderate (n=16) or severe (n=4)
according to the criteria of the NHLBI (10).
Subjects sensitized to pollen were studied out of the
relevant season. The duration of disease ranged from 1?5 to
45 years.
All patients were in a clinically stable condition at the
time of the study and had been receiving daily inhaled
corticosteroids (500–1000mg day71) and/or bronchodila-
tors p.n. (as necessary). Bronchodilators were withheld for
at least 12 h before the study. All subjects had been free
from acute respiratory infections within the preceding 4
weeks. Informed consent was given by each subject and the
study was approved by the Local Ethics Committee.
STUDY DESIGN
In this cross-sectional study patients with stable asthma
were referred from the Institute of Allergology and Clinical
Immunology of the University of Florence. Patients
attended the laboratory in two dierent visits. In the first
visit entry criteria were assessed. At the second visit V’–V
curves were assessed.
LUNG FUNCTION TESTING
Baseline pulmonary function testing was performed by
measuring static and dynamic lung volumes with a water-FIG. 1. Tidal (T) and partial (P) V’–V curves in three dierent pa
(b) tidal flows are greater than those on P V’–V curve; (c) tidal fl
limitation was assessed in the form of FL%VT (CB/AB6100);sealed spirometer (Pulmonet Godart; Sensormedics Corp.,
Yorba Linda, CA, U.S.A.), as previously reported (12). The
normal values for lung volumes are those proposed by the
European Community for Coal and Steel (13). Functional
residual capacity (FRC) was measured by helium dilution
technique (12).
Forced expiratory volume and V’–V curve were recorded
simultaneously at the mouth through a Fleisch type 3
pneumotachograph linear up to 12 l sec71 and volume was
obtained by electrical integration of the flow signal after
careful elimination of the drift of the integrator. The
subjects were seated in a comfortable position, and
breathed through the pneumotachograph for 1–2 min,
avoiding any deep breath or coughs.
They then performed a partial (P) forced expiratory
manoeuvre starting between 40–50% of vital capacity near
the end of a tidal inspiration. Immediately after the end of
this manoeuvre, they inspired from residual volume (RV) to
total lung capacity (TLC) and without breath holding,
performed a maximal (M) expiratory manoeuvre.
Care was taken to obtain sharp peak flows on bothM and P
manoeuvres with a rapid fall-o to a curvilinear flow-volume
configuration in order to assure supramaximal transpulmon-
ary pressure to minimize gas compression artifacts (14).
The ratio of V’max on the complete and partial curves at
isovolumic points as recorded by a spirometer and
measured at 60% of vital capacity (VC) from total lung
capacity (TLC) was expressed as the M/P ratio (15). Only
V’–V curves with sharp peak flow were retained for
analysis. Reproducible M/P combined manoeuvres per
subject were obtained.
ASSESSMENT OF DEGREE OF FLOW
LIMITATION
It is known that in asthmatic subjects dynamic compression
of the airways may occur at low transpulmonary pressure
(16). Consequently, during quiet breathing subjects may
develop pressures in excess of transpulmonary pressure
necessary to reach maximal flow. This condition is the base
of developing flow limitation (FL) (7). Expiratory FL was
detected when tidal flows were superimposed or exceededtients: (a) P V’–V curve does not impinge on T V’–V loop;
ows are superimposed on P V’–V curve. The degree of flow
absence of flow limitation was labelled 0 FL.
696 M. FILIPPELLI ET AL.those obtained during partial (P) expiratory V’–V curve. In
the present study, as shown in Fig. 1, we expressed the
partial flow limited segment as a percentage of the total
tidal volume (VT) segment.
The degree of FL was assessed using FL%VT in partial
curves as a continuous variable. The absence of FL was
labelled 0FL.
STATISTICAL ANALYSIS
The statistical analysis carried out considers the depen-
dency of a variable (e.g. the degree of dyspnoea in terms of
MRC and BDI scores) on a series of independent variables.
The eect of each variable on breathlessness was evaluated
independently of the eect of all other variables. In a multi-
variate analysis a rule of thumb is to limit the number of
variables as a function of the number of subjects (17). Thus,
we performed a multiple regression analysis that fits a
random variable to a set of explanatory variables to provide
regression coecient for a linear model. Stepwise selection
of the independent variables was carried out by relating
breathlessness to demographic and functional variables.
Single regression analysis was performed by Pearson’s
single correlation coecient. Comparison between groups
was made by the Mann–Whitney U-test. P<0?05 was
considered as the threshold of statistical significance.
With dyspnoea scale being the gold standard, we
calculated diagnostic accuracy (specificity and sensitivity)
for FEV1 and FL. Receiver operating characteristics
analysis (ROC) (18) was undertaken in order to assess
dierences in sensitivity and specificity between FEV1 and
FL. We used the ROC analysis plots for assessing the indexTABLE 1. Anthropometric and clinical data of the 40 patients
Sex (M/F)
Age
(years)
BM
(kgm
All patients
Mean 15/25 42?2 26?0
SD 16 5?0
Median 42 25?
Range 18–70 17?5–
FL
Mean 8/12 54?25 28?8
SD 10?6 5?2
Median 55?5 27?
Range 27–70 23–45
NFL
Mean 7/13 30?15 23?
SD 11?07 2?6
Median 27?5 23
Range 18–57 17?5–3
P= 0?000005 0?00
BMI: body mass index; MRC: Medical Research Council scale;
non-flow-limited patients.of accuracy of the single diagnostic test and then we
quantified the dierences between the tests by comparing
the area under the ROC plots. ROC plots provide a pure
index of accuracy by demonstrating the limitations of a
test’s ability to discriminate between alternative status of
health over the complete spectrum of operating conditions.
ROC plots occupy a central or unifying position in the
process of assessing and using diagnostic tools. The ROC
graph is a plot of all sensitivity-specificity pairs that results
from continuously varying the decision threshold of the
entire range of observations. Values are means SD.
Results
Anthropometric and clinical characteristics of the patients
are shown in Table 1. Mean body mass index (BMI=
kgm72) was within the normal range although one patient
was under-nourished (BMI518 ) and seven were over-
weight (BMI 28). Dyspnoea ranged from 0 to IV on the
MRC scale and from 12 to 0 on BDI. As shown in Table 2,
patients were mildly obstructed (FEV1/VC 66?9%); the
FRC ranged from normal values through mild to moderate
increase (hyper-inflation). The average M/P value was 1?07
(0?41), range 0?22–2?30.
Patients with flow limitation (FL) were older, with a
higher BMI, more dyspnoeic, with greater FRC and lower
FEV1, VC, FEV1/VC and M/P ratio than patients without
FL (NFL) (P50?03–P50?000005) (see Tables 1, 2 and
Fig. 2).
Pearson’s correlation coecients among dyspnoea scores
and demographic and function data are shown in Table 3I
72)
Duration of disease
(years) MRC BDI
4 11?12 1?6 8?5
11?96 1?15 2?8
0 6?5 2?0 9?0
46 1?5–45 0–4 0–12
5 14?7 2?2 7?2
15?6 1?01 3?05
2 7?0 2?0 7?50
.7 1?5–45 0–4 1–12
2 8?35 1?00 9?75
4 7?63 0?97 1?83
5?0 1?0 9?5
0?1 2?0–30 0?3 7–12
01 NS 0?0004 0?003
BDI: baseline dyspnea index; FL: flow-limited patients; NFL:
TABLE 2. Functional data of the 40 patients
VC FRC RV FEV1 FEV1/VC
(%)
M/P
(l) (% pv) (l) (% pv) (l) (%pv) (l) (% pv)
All patients
Mean 3?8 102?5 3?2 121?4 2?2 129 2?5 84?5 66?9 1?07
SD 1?14 16 0?8 16?3 0?7 32 0?9 21?4 12?5 0?41
Median 3?7 104?8 3?0 118?0 2?0 120 2?3 89 66?4 1?0
Range 1?9–6?7 65–136 1?9–4?7 94–175 1?34–3?6 87–211 0?8–5 32?5–118 36?4–92 0?2–2?3
FL
Mean 3?15 96?5 3?04 129 2?5 137 1?9 74 60?6 0?85
SD 0?82 17?4 0?84 15 0?7 32 0?4 22 12?3 0?34
Median 3?12 96?5 2?8 125 2?3 131 1?9 71 59 0?8
Range 1?9–4?9 65?3–136 1?9–4?3 115–174 1?7–3?6 89–211 0?8–2?8 32?5–108 36?4–82 0?2–1?6
NFL
Mean 4?4 108?4 3?3 114 1?9 120 3?2 95 73?25 1?3
SD 1?06 12?2 0?8 17 0?5 32 0?8 15 9?2 0?36
Median 4 106?8 3?2 112 1?8 111 3?1 98 73 1?2
Range 3?2–6?6 85–128 2?4–4?7 94–147 1?3–3?2 87–207 2?3–5 70–118 58?5–92 0?9–2?3
P= 0?017 0?03 0?1 0?001 0?0007 0?0002
VC: inspiratory vital capacity; FRC: functional residual capacity (helium technique); RV: residual volume; FEV1: forced
expiratory volume in 1 sec; M/P: maximal to partial flow at the 60% of VC; pv: predicted value; FL: flow-limited patients;
NFL: non-flow-limited patients.
FIG. 2. Individual values of BDI, FEV1 and flow limitation (FL) for the 40 patients. Flow limited patients (*), non-flow-
limited patients (*).
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r=70?35; BMI: r= 0?34), VC (r=70?4 and r= 0?47),
FEV1 (r = 70?5 and r = 0?5) and FEV1/VC (r =70?47
and r= 0?41) were related to MRC and BDI, respectively.
FL was related to MRC (r = 0?44), BDI (r =70?44) and
M/P (r = 70?35). The above variables were entered in thestepwise multiple regression analysis (MRA). MRA showed
that (Table 4) FEV1 (P<0?003, r
2 = 15?3% and P<0?004,
r2 = 20?3%) and age (P<0?0006, r2 = 26?8% and
p<0?016, r2 = 11%) independently predicted a part of
the variance of MRC (P< 0?0001, r2 = 42?1%) and BDI
(P< 0?0008, r2 = 31?3%), respectively.
TABLE 3. Relationship between dyspnoea score, demographic characteristics and functional data
Age BMI MRC BDI VC FEV1 FEV1/VC FL M/P
Age — NS 0?45 70?35 NS NS 70?39 0?58 70?70
BMI — 0?34 NS NS NS NS 0?55 NS
MRC — 70?87 70?4 70?50 70?47 0?44 0?41
BDI — 0?47 0?5 0?41 70?44 70?47
VC — 0?84 0?41 70?46 NS
FEV1 — 70?82 70?59 NS
FEV1/VC — 70?59 NS
FL — 70?35
M/P —
BMI: body mass index; MRC: Medical Research Council scale; BDI: baseline dyspnoea index; VC: inspiratory vital capacity;
FEV1: forced expiratory volume in 1 sec; FL: flow-limited patients; M/P: maximal to partial flow at the 60% of VC.
FIG. 3. Relationships of the MRC and BDI scales with age and FEV1. Individual data point are shown. Flow-limited
patients (*), non-flow-limited patients (*).
698 M. FILIPPELLI ET AL.An arbitrary cut-o on MRC and BDI scales separated
patients with moderate to severe dyspnoea (grade II to IV
and 0 to 8 whose FEV1 ranged from 32?5 to 115?0% p.v.
and FL ranged from 0 to 92?1%) from those with mild to
no dyspnoea (0 to I and 9 to 12 on MRC and BDI whose
FEV1 ranged from 56?9 to 117?6% p.v. and FL ranged
from 0 to 78?0%). Patients were further divided into two
subgroups: those without dyspnoea (MRC= 0 and BDI =
12) and those with dyspnoea (MRC = I to IV and BDI =11 to 0). Diagnostic accuracy (sensitivity and specificity) of
FEV1 and FL did not dier in either model (ROC analysis
P= 0?87 to 0?12) (Fig. 4).
Discussion
We have found that in patients with chronic bronchial
asthma, a moderate to severe degree of dyspnoea may be
TABLE 4. Stepwise multiple regression analysis in the 40 patients
Dependent variables
MRC BDI
Independent
variables
P5 r2(%) Independent
variables
P5 r2(%)
0.0001 42.1 0.0008 31.3
Age Age
BMI Age 0.0006 26.8 FEV1 Age 0.016 11.0
FEV1 FEV1 0.003 15.3 VC FEV1 0.004 20.3
VC FL
FL
MRC: Medical Research Council scale; BDI: baseline dyspnoea index; BMI: body mass index; FEV1: forced expiratory
volume in 1 sec; VC: inspiratory vital capacity; FL: flow limited patients.
DYSPNOEA IN CHRONIC ASTHMA 699associated with FL. After adjusting for all other variables,
FEV1 and age but not FL explained a part of CED
variability, the greatest part of which remaining, however,
unexplained. Diagnostic accuracy was similar for FEV1 and
FL in either model of CED.FIG. 4. Comparative course of sensitivity and 1-specificity
for dierent thresholds: FL (~), FEV1 (*). ROC analysis
performed including patients with or without dyspnea
(BDI). The area under the curves for each test reveals no
dierence in terms of diagnostic accuracy between FEV1
and FL.CRITICISM OF THE METHOD
Because we based our FL on partial V’–V curves on exhaled
volumes using a spirometer rather than upon changes in
lung volume by means of a plethysmograph, any dierences
in gas compression during the partial vs. the tidal
manoeuvre would influence our results. Artifacts due to
gas compression under-estimates maximal flow for a given
volume at any given transpulmonary pressure (19). How-
ever, the following must be considered: (i) gas compression
is lower at lower lung volumes in asthma (20), suggesting
that gas compression on partial V’–V curves is negligible;
(ii) residual volume (RV) did not significantly dier in the
FL and NFL groups: this is an important point considering
that there is more gas available for compression when RV
increases (19); (iii) Pellegrino et al. (15) have recently shown
that the FL pattern obtained with body-plethysmograph
during methacholine-induced severe airway narrowing was
similar to that obtained by measuring exhaled lung volumes
in patients with asthma. Thus, we believe that the error due
to gas compression is not sucient to aect our results
qualitatively.
ASTHMA AND FL
Flow-limited patients presented significantly higher FRC.
When flow limitation is reached, patients could increase end
expiratory lung volume (EELV) to avoid flow limitation
(7,15).
Half of our patients with clinically stable bronchial
asthma exhibited FL. These findings are in contrast with
those of Boczkowski et al. (9), obtained by using negative
external pressure (NEP). In that study, NEP, which is
700 M. FILIPPELLI ET AL.thought to be the best technique for assessing FL (6,9,21),
was not able to demonstrate consistent FL in asthmatics.
However, due to the clinical dierences in the two studied
groups, the results of Boczkowski et al. (9) and the present
ones are not comparable. In fact our patients were, on the
average, more dyspnoeic than patients of Boczkowski et al.
(9), 10/13 of whom exhibited grade I/V on a modified
Canadian MRC scale. In addition, the median MRC value
was, in that study (9), lower than that of our FL patients
and similar to that of NFL patients in the present study.
By utilizing partial V’–V curves we avoided the eect of
the time history (22) and the bronchoconstrictor eect of
deep inhalation (DI) in stable asthmatic patients (23, 24).
On the other hand, after a partial V’–V curve, a maximal
V’–V curve and isovolumic maximal to partial (M/P) ratio
were calculated. Patients with FL had a lower M/P ratio as
compared to NFL patients. With the limitation imposed by
a wide range of values (0?2–2?6) a <1 M/P ratio might
indicate predominant inflammatory activity, perhaps more
peripherally, associated with predominant parenchymal
hysteresis (23,24). Alternatively, airway wall inflammation
which opposes to alveolar stretching on airway wall with
loss of pulmonary airway interdependence may explain a
low M/P ratio (25). Whatever the explanation, these data
are consistent with a peripheral airway involvement in FL
patients.
DYSPNOEA, DEMOGRAPHIC
CHARACTERISTICS AND LUNG
FUNCTION
The low level of significance of the relationship between
CED and FEV1 is in line with previous data from the
literature (2,4) and confirms that most of the variance in
CED remains unexplained. FL in COPD patients appears
to be the best predictor of a MRC score after adjusting for
FEV1 (6), but was not an independent predictor of CED in
asthmatics. The observation that age and FEV1 were
independent predictors of dyspnoea is consistent with the
observation that, despite impaired awareness of broncho-
constriction in old age, symptoms associated with airways
obstruction increase in prevalence with increasing age (26).
On the contrary, Bailey et al. (27), in three groups of
patients (5 59, 60–69,  70 years), reported that while the
incidence of symptoms decreased with age, baseline
pulmonary function deteriorated as patients aged. How-
ever, these latter findings are not comparable with the
results of our study since the median age of our patients was
42 years.
In our analysis, BMI was not an independent predictor of
dyspnoea, in agreement with the findings of a recent study
of ours carried out by applying factor analysis (28). In that
study we were able to find that, unlike dyspnea, BMI had
insucient weight to significantly load on a unique factor
(28).
In turn, a large part of the variance of breathlessness
remains unexplained. In general, the experience of breath-
lessness, or the severity of prior symptoms may modulate
subsequent estimates of dyspnoea. The operating charac-teristics of such a nonlinear system would change con-
tinuously (29) so that it may be dicult to predict
breathlessness during daily activity of the life from airway
measurements in patients with chronic bronchial asthma.
SENSITIVITY ANALYSIS
With dyspnoea scale being the gold standard, we worked
out diagnostic accuracy (specificity and sensitivity) for
FEV1 and FL. A detailed analysis by ROC indicated that
the diagnostic accuracy of FEV1 and FL did not dier in
either model (Fig. 4), indicating that the diagnostic
accuracy was indierent to severity of dyspnoea.
The above results indicate that, unlike in patients with
COPD (6), the sensitivity analysis in chronic bronchial
asthma patients underlines the similar role of routine
spirometry measurement of airway obstruction and FL in
assessing the intensity of CED.
In conclusion, FL may be present in this subset of
asthmatics. CED may not be easily explained by abnorm-
alities of routine spirometry or FL, the largest part of the
CED variance remaining unexplained. Thus, routine
spirometry, FL and CED in bronchial asthma subjects
are only partially overlapping quantities which need to be
assessed separately.
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